US Patent Issued to MINNEAMRITA THERAPEUTICS on June 2 for "Triptolide formulations" (Florida Inventor)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,772, issued on June 2, was assigned to MINNEAMRITA THERAPEUTICS LLC (Tampa, Fla.).

"Triptolide formulations" was invented by Mohana R. Velagapudi (Tampa, Fla.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A pharmaceutical composition containing triptolide or a derivative thereof, as well as methods of using the composition and methods of manufacturing the composition. The composition can be prepared using thermokinetic compounding and can provide improved properties, such as improved bioavailability. The composition can improve the therapeutic treatment of cancers such as pancreatic cancer, breast cancer, bladder cancer, kidney cancer, ovarian cance...